Minimal Residual Disease Market: Clinical Applications, Reimbursement Hurdles and Competitive Dynamics Beyond technology, the minimal residual disease market is shaped by where MRD results are used in patient care and how providers and payers respond. Polaris Market Research values the global market at USD 2.38 billion in 2025 and projects USD 7.20 billion by 2034, at a CAGR of 13.1% from 2026...